The high demand for initial lots of COVID-19 vaccines and the likely inevitable dissatisfaction was on full display at public meeting on the National Academies of Medicine’s draft equitable allocation strategy, as many groups clamored to make the case as to why various populations should be near the front of the line, but few offered suggestions as how to fairly prioritize within equally deserving segments of the population.
The public’s perception of the rollout may also be confused by speedy guidance development process that has multiple national health...







